Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort [Removal]
- DOI
- 10.2147/itt.s645886
- Published
- 2026-08
- Container
- ImmunoTargets and Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/itt.s645886,
title = {Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort [Removal]},
author = {Małgorzata Mitura-Lesiuk and Patrycja Najda and Oliwia Rdzanek and Julia Bogucka and Karolina Różycka and Maciej Dubaj and Joanna Zawitkowska},
year = {2026},
journal = {ImmunoTargets and Therapy},
doi = {10.2147/itt.s645886},
url = {https://doi.org/10.2147/itt.s645886}
}RIS
TY - JOUR TI - Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort [Removal] AU - Małgorzata Mitura-Lesiuk AU - Patrycja Najda AU - Oliwia Rdzanek AU - Julia Bogucka AU - Karolina Różycka AU - Maciej Dubaj AU - Joanna Zawitkowska PY - 2026 JO - ImmunoTargets and Therapy DO - 10.2147/itt.s645886 UR - https://doi.org/10.2147/itt.s645886 ER -
APA
Mitura-Lesiuk, M., Najda, P., Rdzanek, O., Bogucka, J., Różycka, K., Dubaj, M., & Zawitkowska, J. (2026). Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort [Removal]. ImmunoTargets and Therapy. https://doi.org/10.2147/itt.s645886
Source records
- crossref · retrieved 2026-09-26T05:58:41.859Z